A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

NCT05758519 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1220

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: QLS1128
DRUG: Placebo

Sponsor

Qilu Pharmaceutical Co., Ltd.